SUBSCRIBE
SUBSCRIBE
News   Policy

Merck & Co., Inc., Cardiome Pharma Corp. Heart Drug Gets Positive EU Review

June 25, 2010 | 
1 min read
LONDON, June 25 (Reuters) - The European Medicines Agency has recommended Merck & Co's (MRK.N) drug Brinavess, or vernakalant, as a treatment for acute atrial fibrillation, or irregular heart beats, the London-based regulator said on Friday.
Regulatory Europe
Merck & Co.
MORE ON THIS TOPIC
Human brain with abstract visualization of neuron activity
Huntington’s disease
FDA Official Fires Back at UniQure, Doubles Down on Sham-Controlled Trial
March 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Business decision concept with a businessman standing on a huge question mark. Symbol of the future, opportunities, planning, vision. Vector illustration
Regulatory
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of a yellow envelope on a blue background with a read warning symbol
Supply chain
FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP-1s
March 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor